Waldencast Acquisition Corp

Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It intends to seek brands with a direct connection to consumers whose goals include pursuing social responsibility, inclusiveness, sustainability, and transparency. The company was founded by Michel Brousset and Hind Sebti in December 2020 and is headquartered in White Plains, NY.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It intends to seek brands with a direct connection to consumers whose goals include pursuing social responsibility, inclusiveness, sustainability, and transparency. The company was founded by Michel Brousset and Hind Sebti on December 8, 2020 and is headquartered in White Plains, NY.

This New Product is the Latest Introduction to Obagi's Daily Hydro-Drops® Collection This New Product is the Latest Introduction to Obagi's Daily Hydro-Drops® Collection

Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream

NEW YORK , March 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc ("Waldencast" or the "Company") (NASDAQ: WALD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD

NEW YORK, Feb. 29, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Waldencast PLC (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Waldencast PLC (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee.

ROSEN, A LEADING LAW FIRM, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation – WALD, WALDW

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced that by decision dated February 22, 2024, a Nasdaq Hearings Panel (the “Panel”) granted Waldencast's request for continued listing on The Nasdaq Stock Market LLC (“Nasdaq”), subject to Waldencast filing the interim financial statements for the six-month period ended June 30, 2023 with the Securities and Exchange Commission by April 1, 2024, and Waldencast's continued compliance with all other applicable criteria for continued listing on Nasdaq. Waldencast is diligently working to evidence compliance with the terms of the Panel's decision as soon as practicable and in any event by no later than April 1, 2024.

Waldencast Receives Positive Nasdaq Listing Determination

NEW YORK--(BUSINESS WIRE)---- $WALD #classaction--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Waldencast plc (“Waldencast” or “the Company”) (NASDAQ: WALD, WALDW). Investors who purchased Waldencast securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WALD. Investigation Details: On November 15, 2021, Waldencast issued a press release announcing entry into a busines.

Waldencast plc (WALD, WALDW) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Company Appoints Renowned Mazdack Rassi as Waldencast's Global Brand Director to Lead the Creative Council and Brand Positioning Company Appoints Renowned Mazdack Rassi as Waldencast's Global Brand Director to Lead the Creative Council and Brand Positioning

Waldencast Announces New “Creative Council” of Industry Pioneers and Disruptors

LONG BEACH, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC (“Obagi”), a leader in skincare innovation and the originator of medical-grade skincare, is thrilled to announce the appointment of Dr. Suzan Obagi as the Company's first-ever Chief Medical Director. Obagi is a subsidiary of Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform and publicly listed company. Dr. Obagi brings a wealth of experience and expertise to her role, further solidifying Obagi's commitment to providing advanced, transformative skincare solutions.

Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.

NEW YORK, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced its participation in the TD Cowen Glowing Ahead: Beauty & Wellness Summit being held on February 13, 2024 in New York City, New York.

Waldencast Announces Participation in the TD Cowen Glowing Ahead: Beauty & Wellness Summit

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a global multi-brand beauty and wellness platform, announced today that Manuel Manfredi will join the Company as Chief Financial Officer on April 1, 2024. Philippe Gautier, currently Chief Financial Officer and Chief Operating Officer is leaving the Company, effective today. Michel Brousset, Founder and Chief Executive Officer of the Company who had previously assumed the combined roles of Chief Executive Officer and Chief Financial Officer prior to the appointment of Mr. Gautier, will serve as the Company's interim Chief Financial Officer through March 31, 2024.

Waldencast Names Manuel Manfredi as Chief Financial Officer

NEW YORK , Jan. 23, 2024 /PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Waldencast plc ("Waldencast") (NASDAQ: WALD) concerning possible violations of federal securities laws. On July 5, 2023, after the market closed, Waldencast filed a current report with the U.S. Securities and Exchange Commission in which it disclosed, among other things that certain financial statements of Obagi, a skin care company that Waldencast had acquired, could no longer be relied upon because Waldencast expected to restate those financial statements.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Waldencast plc (WALD)

NEW YORK , Jan. 19, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Waldencast plc: Due to the forgoing, The Gross Law Firm is investigating potential securities fraud claims on behalf of certain Waldencast investors. If you incurred a loss on your WALD investment, please contact us using the link below to discuss your rights.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Waldencast plc of an Investigation and Potential Class Action Lawsuit - (NASDAQ: WALD)

NEW YORK , Jan. 18, 2024 /PRNewswire/ -- Attention Waldencast plc ("Waldencast") (NASDAQ: WALD) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced into Waldencast and certain of its officers and directors regarding potential securities fraud. The investigation concerns, in part, the below: If you suffered a loss on your investment in Waldencast, contact us about potential recovery by using the link below.

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Investigate Waldencast plc (WALD) for Potential Violations of Securities Laws

NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced that it filed its annual report for the fiscal year ended December 31, 2022 on Form 20-F (“2022 20-F”) including restated financials for Fiscal Years 2021 and 2020 with the securities and exchange commission, which is also available on its investor relations site at https:/ir.waldencast.com/.

Waldencast plc Announces Fiscal Year 2022 Financial Results

NEW YORK , Jan. 16, 2024 /PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Waldencast plc ("Waldencast") (NASDAQ: WALD) concerning possible violations of federal securities laws. On July 5, 2023, after the market closed, Waldencast filed a current report with the U.S. Securities and Exchange Commission in which it disclosed, among other things that certain financial statements of Obagi, a skin care company that Waldencast had acquired, could no longer be relied upon because Waldencast expected to restate those financial statements.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Waldencast plc(WALD)

NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that on January 3, 2024, it received an additional notice of non-compliance from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) due to the Company not having filed interim financial statements for the period ended June 30, 2023 with the Securities and Exchange Commission (the “SEC”) by December 31, 2023, as required by Nasdaq Listing Rule 5250(c)(2) (the “Filing Rule”). The Staff noted that the Nasdaq Hearings Panel (the “Panel”) will consider this additional notice as part of its determination regarding the Company's continued listing on The Nasdaq Capital Market. The additional notice has no immediate impact on the listing of the Company's securities, the suspension of which was stayed by Nasdaq at least pending completion of the hearing process.

Waldencast plc Announces Receipt of Anticipated Nasdaq Delinquency Notice

NEW YORK , Nov. 27, 2023 /PRNewswire/ -- WHY: New York, N.Y., November 27, 2023.

WALD INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW

NEW YORK, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that it received written notice that The Nasdaq Stock Market LLC (“Nasdaq”) granted the Company's previously announced request to extend the stay of the suspension of the Company's securities at least pending completion of the hearing process. Accordingly, the Company's securities will continue to trade on Nasdaq until the Nasdaq Hearings Panel (the “Panel”) issues a final decision regarding the Company's listing status following a hearing scheduled for February 8, 2024 or upon receipt of confirmation from Nasdaq that the Company has regained compliance with Nasdaq's continued listing standards (if earlier). Although the Company is continuing to work diligently to file its Annual Report on Form 20-F for the year ended December 31, 2022 (the “2022 Annual Report”) with the Securities and Exchange Commission (the “SEC”) as soon as practicable, there can be no assurance that the Company will have regained compliance with Nasdaq's continued listing standards ahead of the hearing, and if not, that the Panel will grant a further extension or that the Company will be able to timely satisfy the terms of any extension granted by the Panel.

Waldencast plc Announces Receipt of Nasdaq Listing Stay

NEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that on October 31, 2023, the Company received written notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was subject to delisting from Nasdaq based upon the Company's non-compliance with the filing requirement set forth in Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of periodic reports with the Securities and Exchange Commission (the “SEC”). The Company plans to timely request a hearing before the Nasdaq Hearings Panel (the “Panel”) pursuant to the procedures set forth in the Nasdaq Listing Rules. The Listing Rules also provide that such request will stay any suspension or delisting action for 22 days from the date of the Nasdaq notification. Further, the Listing Rules provide that, in its hearing request, the Company may request that the stay remain in effect through the hearing and the expiration of any additional extension period granted by the Panel following the hearing. Accordingly, the Company intends to make such an extended stay request. If granted, the Company's securities will continue to be listed and trade on The Nasdaq Capital Market under the symbols “WALD” and “WALDW,” respectively, for the stay period granted by the Panel.

Waldencast plc Announces Receipt of Nasdaq Listing Notice

Forafric Global PLC

Symbotic Inc

Did you happen to see Barron's recent  article that discussed Bill Ackman's desire to take X (formerly Twitter) public through his SPARC (special purpose acquisition rights company), a newer twist to SPACs (special purpose acquisition company)? The traditional SPAC raises money in an IPO (initial public offering) and then takes 12-24 months to find a target to merge with.

3 SPACs From 2022 That Are Actually Really Good Buys Now

LOS ANGELES, CA / ACCESSWIRE / August 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Waldencast plc ("Waldencast" or "the Company") (NASDAQ:WALD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Waldencast plc and Encourages Investors with Losses to Contact the Firm

NEW YORK , Aug. 22, 2023 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Waldencast PLC (Nasdaq: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WALD LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Waldencast plc Investors With Losses in Excess of $100K to Inquire About Securities Class Action Investigation - WALD, WALDS

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Waldencast plc (“Waldencast” or the “Company”) (NASDAQ: WALD, WALDW) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Waldencast investments or would like to inquire about potentially pursuing claims to recover your loss under the federal secu.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Waldencast plc (WALD, WALDW) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Waldencast plc (“Waldencast” or the “Company”) (NASDAQ: WALD, WALDW) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On July 5, 2023, Waldencast disclosed that certain previously issued financial statements of Obagi Global Holdings Limited (“Obagi”) should no longer be relied upon bec.

The Law Offices of Frank R. Cruz Announces Investigation of Waldencast plc (WALD, WALDW) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Waldencast plc (“Waldencast” or the “Company”) (NASDAQ: WALD, WALDW) investors concerning the Company's possible violations of federal securities laws. On July 5, 2023, Waldencast disclosed that certain previously issued financial statements of Obagi Global Holdings Limited (“Obagi”) should no longer be relied upon because the Company discovered errors related to revenue recognition in connect.

News for Waldencast Acquisition Corp Stock (WALD)